COLL vs PH
Collegium Pharmaceutical Inc (COLL) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the COLL and PH stock pages for the full models.
Not investment advice.